Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy
Author(s) -
Shikun He,
Ernesto Barrón,
Keijiro Ishikawa,
Hossein Nazari Khanamiri,
Chris Spee,
Peng Zhou,
Satoru Kase,
Zhuoshi Wang,
Laurie Dustin,
David R. Hinton
Publication year - 2015
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.14-16258
Subject(s) - microbiology and biotechnology , transdifferentiation , dna methylation , methylation , vimentin , proliferative vitreoretinopathy , bisulfite sequencing , chemistry , biology , gene expression , cell , retinal , biochemistry , dna , immunohistochemistry , gene , immunology , retinal detachment
The purpose of this study was to evaluate expression of methyl-CpG-binding protein 2 (MeCP2) in epiretinal membranes from patients with proliferative vitreoretinopathy (PVR) and to investigate effects of inhibition of MeCP2 and DNA methylation on transforming growth factor (TGF)-β-induced retinal pigment epithelial (RPE) cell transdifferentiation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom